The term “educational material” (risk minimization material) refers to supplementary information that is important for the safe use of the medicinal products in question and is provided with the summary of product characteristics and package leaflet for certain medicinal products. The educational material is required when a drug is approved or its approval is changed if, in addition to the summary of product characteristics and package insert, special information is needed to minimize drug risks in medical practice.

Even if the drug is marketed by different pharmaceutical companies, the educational material should be uniform so that the content to be conveyed is perceived equally by the target groups, regardless of the individual drug prescribed or used, and does not cause confusion among users.

Officially approved educational materials are marked with the “Blue Hand” logo and made available on the websites of the Federal Institute for Drugs and Medical Devices and the Paul Ehrlich Institute.

Approved training material published by BfArM on active ingredients and medicinal products within its area of responsibility can be found here:

🔗 Educational material from the BfArM

Educational materials published by the Paul Ehrlich Institute (PEI) on active substances and medicinal products within its area of responsibility can be found here:

🔗 PEI educational materials

If you have any questions or require further information, please do not hesitate to contact us at 0 22 38 94 99 310.
You are also welcome to send your request by email to pv@ebbmedical.com.